21 – 30 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance in medical hospital admissions – a new strategy for screening?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy
(
- Contribution to journal › Article
-
Mark
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma
(
- Contribution to journal › Article
- 2019
-
Mark
Fetal and neonatal alloimmune thrombocytopenia : recommendations for evidence-based practice, an international approach
(
- Contribution to journal › Article
-
Mark
Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia
(
- Contribution to journal › Article
-
Mark
Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia
(
- Contribution to journal › Letter
-
Mark
HAX-1 overexpression in multiple myeloma is associated with poor survival
(
- Contribution to journal › Letter
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article